期刊文献+

MYCT1通过PRSS21抑制喉癌细胞的增殖和迁移 被引量:2

MYCT1 inhibits the proliferation and migration of laryngeal carcinoma cells via PRSS21
下载PDF
导出
摘要 目的探讨MYCT1通过PRSS21对喉癌细胞增殖和迁移的影响。方法应用实时PCR和Western blotting方法检测喉癌中PRSS21的表达水平及MYCT1对PRSS21表达水平的影响;应用CCK-8实验和克隆形成实验检测MYCT1通过PRSS21对喉癌细胞增殖和克隆形成能力的影响;应用划痕实验检测MYCT1通过PRSS21对喉癌细胞迁移能力的影响。结果PRSS21在喉癌中高表达(P<0.05);与对照组相比,MYCT1显著降低PRSS21在喉癌细胞中mRNA和蛋白质的表达水平(P<0.05);MYCT1通过PRSS21显著抑制喉癌细胞的增殖和克隆形成(P<0.05);MYCT1通过PRSS21显著抑制喉癌细胞的迁移能力(P<0.05)。结论MYCT1可通过抑制PRSS21的表达抑制喉癌细胞的增殖和迁移。 Objective To investigate the effects of MYCT1 on the PRSS21-mediated proliferation and migration of laryngeal carcinoma cells.Methods Real-time PCR and Western blotting were used to detect PRSS21 mRNA and protein expression,respectively in the context of MYCT1 silencing or overexpression in laryngeal carcinoma.The CCK-8 and clone formation assays were applied to monitor the effects of MYCT1 on the PRSS21-mediated proliferation and survival of laryngeal cancer cells.A scratch assay was further conducted to monitor the effect of MYCT1 on the migration(PRSS21-mediated)of laryngeal cancer cells.Results PRSS21 was highly expressed in laryngeal carcinoma(P<0.05).Compared to controls,MYCT1 significantly inhibited the expression of PRSS21 both at mRNA and protein levels in laryngeal cancer cells(P<0.05).Importantly MYCT1 significantly inhibited the proliferation,clone formation,and migration of laryngeal carcinoma cells,in a PRSS21 dependent fashion(P<0.05).Conclusion MYCT1 represses the proliferation and migration of laryngeal carcinoma cells via the inhibition of PRSS21 expression.
作者 陈芸 孙媛媛 富伟能 CHEN Yun;SUN Yuanyuan;FU Weineng(Department of Medical Genetics,School of Life Science,China Medical University,Shenyang 110122,China)
出处 《中国医科大学学报》 CAS CSCD 北大核心 2020年第10期876-881,共6页 Journal of China Medical University
基金 国家自然科学基金(81372876) 辽宁省重点研发计划(2017225021) 辽宁省高等学校基本科研项目(LQNK201726)。
关键词 MYCT1 PRSS21 喉癌 增殖 迁移 MYCT1 PRSS21 laryngeal carcinoma proliferation migration
  • 相关文献

参考文献1

二级参考文献15

  • 1Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature, 2001, 409∶860-921.
  • 2Huminiecki L, Bicknell R. In silicon cloning of novel endothelial-specific genes. Genome Res, 2000,10∶1796-1806.
  • 3Peterson DG, Schulze SR, Sciara EB, et al. Integration of Cot analysis, DNA cloning, and high-throughput sequencing facilitates genome characterization and gene discovery. Genome Res,2002,12∶795-807.
  • 4Henriksson M, Luscher B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res, 1996, 68∶109-82.
  • 5Facchini LM, Penn LZ. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J, 1998, 12∶633-651.
  • 6Obaya A, Mateyak MK, Sedivy JM. Mysterious liaisons: the relationship between c-Myc and the cell cycle. Oncogene, 1999,18∶2934-2941.
  • 7Prendergast GC. Mechanisms of apoptosis by c-Myc. Oncogene, 1999, 18∶2967-2987.
  • 8Iritani BM, Eisenman RN. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc Natl Acad Sci U S A, 2000, 97∶10544-10548.
  • 9Brandvold KA, Neiman P, Ruddell A. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene, 2000, 19∶2780-2785.
  • 10Yin XY, Grove L, Datta N, et al. C-myc overexpression and p53 loss cooperate to promote genomic instability. Oncogene, 1999,17∶1177-1184.

共引文献23

同被引文献18

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部